Kekule Pharma Limited was established in 1984 and approved by USFDA. We are leading manufacturers of Advance intermediates and Active Pharmaceutical Ingredients (API) and also specialized in the development of innovative processes for the synthesis of a wide range of products. Our facility has audited by several MNC companies and supplying our APIs and Advance intermediates to various countries. Recently our facility was audited by MFDS and submitted our observations. 

Our strong API and Advance intermediates products: 
Etoricoxib

Celecoxib

Pantoprazole Sodium

Quetiapine Fumarate

Telmisartan

Citalopram Hbr

Benfotiamine

Famotidine

Citicoline

Eletriptan

Flurbiprofen

Ractopamine

Sevelamer HCl

Tofacitinib Citrate

Fosaprepitant


Oncology API Products :
Bicalutamide

Nilutamide

Imatinib

Capecitabine

Gefitinib

Pazopanib

Busulphan

Cyclophosphemide

Cytarabine

Dacarbazine

Melphalan

Abiraterone acetate

Pemetrexed disodium heptahydrate

Bortezomib

Docetaxel

Ifosfamide (Non sterile)

Irinotecan hcl

Temozolamide

Gemcitabine
Please contact us @ [email protected] Mobile / whatsup number : 00919849798889

Sales Markets

Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America

Primary business activity

Manufacturer

Meet us at

CPhI & PMEC India 2020

India Expo Centre, Greater Noida, Delhi NCR

25 - 27 November 2020

Book a meeting
View Our Exhibitor Profile

Contact information

Address

Telephone

Website

View All Contact Info

Top Products

Bicalutamide

Kekule Pharma Limited

Request Info

Bicalutamide Intermediate

Kekule Pharma Limited

Request Info

Celecoxib

Kekule Pharma Limited

Request Info

Celecoxib Intermediate

Kekule Pharma Limited

Request Info